Latest Breaking News On - Flavius martin - Page 1 : comparemela.com

Gilead Sciences strengthens commitment to inflammatory disease with new research site

Gilead Sciences has celebrated the opening of its new research site at the Business Park in Oxford with a ribbon-cutting event.

United kingdomUnited statesLynne murrayFlavius martinAnneliese doddsOxford universityGilead sciencesOxford at gilead sciencesOxford eastBio developmentsBiopharma cultureEmerging marketsInflammatory diseasesInflammatory disorders

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, headquartered in Holon, Israel, to exclusively license its potential first-in-class, pre-clinical antibody .

Foster cityUnited statesIsrael generalSan franciscoTel avivFlavius martinCompugen ltdGilead public affairsSecurities exchangeGilead sciences incTel aviv stock exchangeExchange commissionRights to later stage developmentTerms of the partnershipGilead sciencesGilead will have exclusive rights

Gilead gains rights to Compugen s immunotherapy programme in deal worth up to $848m

Gilead gains rights to Compugen s immunotherapy programme in deal worth up to $848m
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Flavius martinGilead sciencesAnat cohen dayag

Gilead Sciences and Compugen strike commercialization deal for immunotherapy program

Gilead Sciences and Compugen strike commercialization deal for immunotherapy program
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Flavius martinDrug administrationCompugen ltdGilead sciences incGilead sciencesInvestigational new drugAnat cohen dayag

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tel avivUnited statesSan franciscoFoster cityIsrael generalYvonne naughtonMeaghan smithFlavius martinJacquie rossGilead sciences incGilead sciencesRights to later stage developmentTerms of the partnershipExchange commissionCompugen ltdGilead public affairs